326 related articles for article (PubMed ID: 15665304)
1. Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss.
Smith HJ; Mukerji P; Tisdale MJ
Cancer Res; 2005 Jan; 65(1):277-83. PubMed ID: 15665304
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate.
Smith HJ; Wyke SM; Tisdale MJ
Cancer Res; 2004 Dec; 64(23):8731-5. PubMed ID: 15574784
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation.
Whitehouse AS; Tisdale MJ
Biochem Biophys Res Commun; 2001 Jul; 285(3):598-602. PubMed ID: 11453634
[TBL] [Abstract][Full Text] [Related]
4. β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.
Aversa Z; Bonetto A; Costelli P; Minero VG; Penna F; Baccino FM; Lucia S; Rossi Fanelli F; Muscaritoli M
Int J Oncol; 2011 Mar; 38(3):713-20. PubMed ID: 21184031
[TBL] [Abstract][Full Text] [Related]
5. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli.
Eley HL; Russell ST; Baxter JH; Mukerji P; Tisdale MJ
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E923-31. PubMed ID: 17609254
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss.
Khal J; Hine AV; Fearon KC; Dejong CH; Tisdale MJ
Int J Biochem Cell Biol; 2005 Oct; 37(10):2196-206. PubMed ID: 16125116
[TBL] [Abstract][Full Text] [Related]
7. The 'cancer cachectic factor'.
Tisdale MJ
Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA).
Khal J; Tisdale MJ
Biochem Biophys Res Commun; 2008 Oct; 375(2):238-40. PubMed ID: 18703014
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.
Mirza KA; Pereira SL; Voss AC; Tisdale MJ
Nutrition; 2014; 30(7-8):807-13. PubMed ID: 24984997
[TBL] [Abstract][Full Text] [Related]
11. Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway.
Wyke SM; Tisdale MJ
Life Sci; 2006 May; 78(25):2898-910. PubMed ID: 16343552
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of ubiquitin-dependent protein degradation in murine myotubes during hyperthermia by eicosapentaenoic acid.
Smith HJ; Khal J; Tisdale MJ
Biochem Biophys Res Commun; 2005 Jun; 332(1):83-8. PubMed ID: 15896302
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.
Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S
Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114
[TBL] [Abstract][Full Text] [Related]
14. Effect of beta-hydroxy-beta-methylbutyrate (HMB) on protein metabolism in whole body and in selected tissues.
Holecek M; Muthny T; Kovarik M; Sispera L
Food Chem Toxicol; 2009 Jan; 47(1):255-9. PubMed ID: 19056452
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.
Liu Z; Miers WR; Wei L; Barrett EJ
Biochem Biophys Res Commun; 2000 Oct; 276(3):1255-60. PubMed ID: 11027619
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
Tilignac T; Temparis S; Combaret L; Taillandier D; Pouch MN; Cervek M; Cardenas DM; Le Bricon T; Debiton E; Samuels SE; Madelmont JC; Attaix D
Cancer Res; 2002 May; 62(10):2771-7. PubMed ID: 12019153
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of cancer cachexia.
Tisdale MJ
J Support Oncol; 2003; 1(3):159-68. PubMed ID: 15334872
[TBL] [Abstract][Full Text] [Related]
18. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover.
Beck SA; Smith KL; Tisdale MJ
Cancer Res; 1991 Nov; 51(22):6089-93. PubMed ID: 1657378
[TBL] [Abstract][Full Text] [Related]
19. β-Hydroxy-β-methylbutyrate (HMB) normalizes dexamethasone-induced autophagy-lysosomal pathway in skeletal muscle.
Girón MD; Vílchez JD; Shreeram S; Salto R; Manzano M; Cabrera E; Campos N; Edens NK; Rueda R; López-Pedrosa JM
PLoS One; 2015; 10(2):e0117520. PubMed ID: 25658432
[TBL] [Abstract][Full Text] [Related]
20. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF).
Lorite MJ; Smith HJ; Arnold JA; Morris A; Thompson MG; Tisdale MJ
Br J Cancer; 2001 Jul; 85(2):297-302. PubMed ID: 11461093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
